Comparative assessment of the effectiveness of anaesthesia for intravitreal bevacizumab injection

Clinical and Experimental Ophthalmology

Volumn 39, Issue 2, 2011, Pages 184-185

  Lahood, Benjamin R ^a   Sherwood, Derek ^a   Suter, Antony ^a  

^a NELSON MARLBOROUGH DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; LIDOCAINE; OXYBUPROCAINE;

AGED; ANESTHESIA; ANESTHESIA INDUCTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INJECTION PAIN; LETTER; MAJOR CLINICAL STUDY; RETINA MACULA DEGENERATION; VISUAL ANALOG SCALE;

AGED, 80 AND OVER; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; EYE PAIN; HUMANS; INTRAVITREAL INJECTIONS; LIDOCAINE; PAIN MEASUREMENT; PROCAINE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WET MACULAR DEGENERATION;

EID: 79952679447     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02432.x     Document Type: Letter

References (5)

1. Gillies M. Bevacizumab in ophthalmology: the controversy moves forward. Clin Experiment Ophthalmol 2010; 38: 333-4.
2. Fong K, Kirkpatrick N, Mohamed Q, Johnston R. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment. Clin Experiment Ophthalmol 2008; 36: 748-55.
3. Yeoh J, Williams C, Allen P etal. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Clin Experiment Ophthalmol 2008; 36: 449-54.
4. Friedman S, Margo C. Topical gel vs subconjunctival lidocaine for intravitreous injection: a randomized clinical trial. Am J Ophthalmol 2006; 142: 887-8.
5. Cintra L, Lucena L, Da Silva J, Costa R, Scott I, Jorge R. comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging 2009; 40: 13-8.